Clinical trial
Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk…
NCT00335101 · GE Healthcare, Industry · Withdrawn
Key facts
| NCT number | NCT00335101 |
|---|---|
| Title | Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography |
| Lead sponsor | GE Healthcare, Industry |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease (CAD), Renal Impairment, Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Iodixanol, Ioversol, Iopromide |
| Enrollment | 0 |
| Start date | Jun 1, 2006 |
| First posted | Jun 8, 2006 |
| Last update posted | Apr 29, 2019 |
| Countries | Germany, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: